Ferric Carboxymaltose Injection

What is Ferric Carboxymaltose Injection?

Ferric Carboxymaltose Injection is a modern intravenous iron formulation used to treat iron deficiency anemia and anemia associated with chronic kidney disease. It provides a convenient and effective way to replenish iron stores rapidly, which is essential for patients who cannot tolerate or absorb oral iron supplements adequately.

This injection is manufactured by Emcure Pharmaceuticals Ltd., a reputable company known for producing high-quality pharmaceutical products. Its development has revolutionized iron therapy by offering a well-tolerated alternative with fewer doses and quicker results, making it a crucial option for healthcare providers in Canada and worldwide.

Uses of Ferric Carboxymaltose Injection

• Treatment of iron deficiency anemia when oral iron therapy is ineffective or contraindicated
• Management of anemia in patients with chronic kidney disease
• Restoration of iron levels in patients with intolerance to oral iron supplements
• Correction of iron deficiency caused by surgery, heavy menstrual bleeding, or gastrointestinal diseases

How Ferric Carboxymaltose Injection Works

Ferric Carboxymaltose Injection works by delivering a complex of iron directly into the bloodstream, bypassing the gastrointestinal tract. Once administered intravenously, the iron is bound within the carboxymaltose shell and slowly released for uptake by the body's iron stores.

This process allows for rapid replenishment of iron necessary for hemoglobin synthesis and red blood cell production. It supports the body’s oxygen transport capacity, which is critical in managing anemia symptoms and improving patient quality of life.

Benefits of Ferric Carboxymaltose Injection

• Rapid correction of iron deficiency with fewer administrations
• Well-tolerated with a low risk of allergic reactions
• Suitable for patients with poor absorption of oral iron
• Convenient dosing schedule reduces hospital visits
• Improves energy levels and physical performance in anemic patients

Dosage and Administration

Ferric Carboxymaltose Injection should only be administered by a trained healthcare professional. The dosage depends on the patient’s iron deficit calculated through weight and hemoglobin levels.

Typically, a single dose can range up to 1000 mg of iron, administered as an intravenous infusion. Multiple doses may be required for complete iron repletion but should be spaced according to medical advice.

Monitoring of hemoglobin and iron parameters during treatment is essential to ensure safe and effective therapy.

Who Should Use Ferric Carboxymaltose Injection?

Patients diagnosed with iron deficiency anemia who have either not responded to or cannot take oral iron supplements are ideal candidates. It is also recommended for individuals with anemia resulting from chronic kidney disease and other clinical conditions requiring rapid iron replenishment.

Who Should Avoid Ferric Carboxymaltose Injection?

Individuals with known hypersensitivity to Ferric Carboxymaltose or any component of the formulation should avoid this injection. It is not advised for patients with iron overload disorders such as hemochromatosis, hemosiderosis, or those with evidence of significant infection or inflammation unless iron deficiency anemia is clearly established.

Side Effects

• Injection site reactions like pain or swelling
• Headache
• Dizziness
• Nausea
• Flushing
• Hypersensitivity reactions including rash or itching
• Rarely, low blood pressure or anaphylaxis

Safety Advice

• Inform your healthcare provider about any allergy history before administration
• Monitor for signs of hypersensitivity during and after the injection
• Regular blood tests to assess iron status and avoid overload
• Do not use if you have active infections or iron overload
• Use caution in patients with impaired liver function

Drug Interactions

• Concurrent use with oral iron supplements should be avoided
• May interact with certain antibiotics reducing their effectiveness
• Interactions possible with medications affecting iron metabolism
• Consult healthcare provider about all medications to avoid adverse effects

Storage Instructions

Store Ferric Carboxymaltose Injection in a cool, dry place at temperatures between 2°C and 8°C. Protect from light and do not freeze. Use the injection immediately after opening and discard any unused portion according to local regulations.

Where to buy Ferric Carboxymaltose Injection in Canada?

Ferric Carboxymaltose Injection is available through licensed pharmacies and medical supply distributors across Canada. Patients should obtain this medication via a prescription from a healthcare professional. Many Canadian pharmacies also offer home delivery services for convenience.

Frequently Asked Questions (FAQ)

Is Ferric Carboxymaltose Injection available in Canada?

Yes, Ferric Carboxymaltose Injection is approved and available in Canada through prescription from authorized healthcare providers and dispensing pharmacies.

What is the price of Ferric Carboxymaltose Injection in Canada?

Prices may vary based on the pharmacy and dosage required. It is advisable to check with local Canadian pharmacies or healthcare providers for accurate pricing and possible insurance coverage.

What happens if I miss a dose?

If a scheduled dose is missed, consult your healthcare provider promptly. Do not attempt to self-administer or double the next dose without medical advice.

Where can I find Ferric Carboxymaltose Injection for sale?

You can find Ferric Carboxymaltose Injection at licensed Canadian pharmacies, hospital pharmacies, and authorized medical supply channels with a valid prescription.

Are there any special instructions for administration?

The injection must be administered intravenously by trained healthcare professionals adhering to recommended infusion rates and monitoring procedures.

Can Ferric Carboxymaltose Injection be used during pregnancy?

Consult your doctor before use. While iron supplementation may be necessary in pregnancy, safety depends on individual medical condition and risk assessments.

How long does it take to see improvements after using Ferric Carboxymaltose Injection?

Improvements in iron levels and anemia symptoms can be observed within days to weeks, depending on the patient’s iron deficiency severity and overall health status.

Conclusion

Ferric Carboxymaltose Injection is a valuable treatment option for managing iron deficiency anemia effectively and safely. Its ability to rapidly replenish iron stores with minimal administrations makes it an essential therapy for patients in Canada and beyond. Always use this medication under the supervision of a qualified healthcare professional to ensure optimal outcomes and safety.